Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery.

导出 OA

翻译打印收藏纠错

作者： Nathaniel B,Verhagen ^[1] ; Nicolas K,Koerber ^[1] ; Aniko,Szabo ^[2] ; Bradley,Taylor ^[3] ; J Njeri,Wainaina ^[4] ; Douglas B,Evans ^[1] ; Anai N,Kothari ^[5] ; N3C Consortium ^[6]

作者单位： Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, 8701, USA. ^[1] Department of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA. ^[2] Clinical and Translational Science Institute of Southeastern Wisconsin, Froedtert and Medical College of Wisconsin Health Network, Milwaukee, WI, USA. ^[3] Division of Infectious Disease, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. ^[4] Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, 8701, USA. akothari@mcw.edu. ^[5] Clinical and Translational Science Institute of Southeastern Wisconsin, Froedtert and Medical College of Wisconsin Health Network, Milwaukee, WI, USA. akothari@mcw.edu. ^[6]

主题词人类(Humans);肿瘤(Neoplasms);病人(Patients);接种(Vaccination)

DOI 10.1245/s10434-022-12916-z

PMID 36479662

发布时间 2023-10-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交